Search results for "Coin"

showing 10 items of 612 documents

Evidence of oblate-prolate shape coexistence in the strongly-deformed nucleus 119Cs

2021

International audience; Prolate-oblate shape coexistence close to the ground state in the strongly-deformed proton-rich A≈120 nuclei is reported for the first time. One of the four reported bands in 119Cs, built on a 11/2− state at 670 keV, consists of nearly degenerate signature partners, and has properties which unequivocally indicate the strongly-coupled πh11/2[505]11/2− configuration associated with oblate shape. Together with the decoupled πh11/2[541]3/2− band built on the 11/2− prolate state at 110 keV, for which a half-life of T1/2=55(5)μs has been measured, the new bands bring evidence of shape coexistence at low spin in the proton-rich strongly deformed A≈120 nuclei, a phenomenon p…

58Ni(64Zn3p)119CsNuclear reactionNuclear and High Energy PhysicsQC1-999Nuclear TheoryModel calculation-coincidences[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]01 natural sciencesMolecular physicsMeasured γγγ-coincidencescesium0103 physical sciencesmedicineNuclear reaction:58Ni(64Zn3p)119CsZnCovariant transformationCs010306 general physicsSpin (physics)Ni(PhysicsLinear polarization010308 nuclear & particles physicsLinear polarizationPhysicsDegenerate energy levels3p)Oblate-prolate coexistenceNuclear reactionmedicine.anatomical_structureNuclear reaction:Angular correlationsDensity functional theoryydinfysiikkaGround stateMeasuredNucleusPhysics Letters B
researchProduct

La ceca de Olkairun y su posible localización = The mint of Olkairun and its possible localization

2018

Este artículo estudia el actual estado de cuestión sobre una de las más raras y problemáticas cecas prerromanas de la Península Ibérica. Tradicionalmente descrita como ceca vascona situada en Navarra, debatimos sobre su posible etnómino y ulterior localización. Un nuevo hallazgo procedente de Cigales (Valladolid) permite plantear un giro interpretativo respecto a las antiguas hipótesis, considerando actualmente la situación de la ceca en un lugar más al sur, quizás sobre la cabecera meridional del valle alto del Ebro.

:HISTORIA::Historia por épocas [UNESCO]UNESCO::HISTORIA::Historia por épocasvasconian/celtiberian mintcoin findsUNESCO::HISTORIA::Ciencias auxiliares de la historiaceca vascona/celtibéricaCigales:HISTORIA::Ciencias auxiliares de la historia [UNESCO]hallazgos monetarioslocalizaciónlocalization
researchProduct

Multiple scattering approach for two-electron resonant emission studied by angle-resolved coincidence spectroscopy.

2008

International audience; We have developed a generalization of the multiple-scattering formalism to deal with Auger-photoelectron coincidence spectroscopy APECS in the solid state. We have merged the exact atomic treatment of the angular correlations between the two electrons and the single-particle approach, on which the multiplescattering description of condensed matter relies. This allows the recovering, even in extended systems, of the entangled form of the electron-pair wave function characterizing the coincidence angular diffraction pattern. In the atomic limit our formalism correctly reproduces the cross section, as calculated within the statistical-tensors approach, usually employed …

ABSORPTION FINE-STRUCTUREPhysicsDiffraction[PHYS]Physics [physics]ScatteringSolid-state02 engineering and technologyElectron021001 nanoscience & nanotechnologyCondensed Matter Physics01 natural sciencesCoincidenceElectronic Optical and Magnetic Materials0103 physical sciencesPHOTOELECTRONELECTRONAtomic physics010306 general physics0210 nano-technologySpectroscopyAnisotropyWave functionPACS 79.60.Bm
researchProduct

Co-colonization with carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii in intensive care unit patients

2013

Objectives: This investigation was conducted to study co-colonization by carbapenem-resistant Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp) and Acinetobacter baumannii (CRAB) in intensive care unit (ICU) patients in Palermo, Sicily, a geographic area where both organisms are endemic in the healthcare setting. Risk factors at admission and during ICU stay and outcomes were also evaluated. Methods: All patients colonized by KPC-Kp, or CRAB, or both in 2 ICUs of a large general hospital during the period October 2011 – March 2012 were enrolled. Demographics and clinical data were collected. Resistance determinants and clonality of the 2 organisms were characterized by mo…

Acinetobacter baumanniiAdultMaleMicrobiology (medical)medicine.medical_specialtyPediatricsYounger ageGenotypeCarbapenem resistant Klebsiella pneumoniaeKlebsiella pneumoniaeCritical IllnessSettore MED/42 - Igiene Generale E ApplicataHospitals Generalbeta-Lactamaseslaw.inventionBacterial ProteinsRisk FactorslawInternal medicineDrug Resistance BacterialmedicineHumansGeneral hospitalSicilyAgedAged 80 and overGeneral Immunology and MicrobiologybiologyCoinfectionbusiness.industryMajor traumaGeneral MedicineMiddle Agedbiology.organism_classificationmedicine.diseaseIntensive care unitCarbapenem resistance co-colonization intensive care unit risk factorsKlebsiella InfectionsAcinetobacter baumanniiMolecular TypingIntensive Care UnitsKlebsiella pneumoniaeInfectious DiseasesFemaleCo colonizationbusinessAcinetobacter InfectionsScandinavian Journal of Infectious Diseases
researchProduct

Impaired T-cell-dependent protection againstLeishmania majorinfection in HIV-positive patients is associated with worsened disease outcome

2015

Cutaneous leishmaniasis (CL) patients coinfected with HIV are known to show a more severe, prolonged course of disease; the immunological basis is not known. We now assessed clinical features, sera and skin biopsies of HIV(+) and HIV(-) patients with CL to identify drivers of increased susceptibility to Leishmania. CL lesion numbers, surface, and healing duration were significantly increased in HIV(+) as compared to HIV(-) patients (2.5, 14 and4-fold, respectively). Patients with HIV infection exhibited lower serum Leishmania-specific IgG levels and decreased IL-6 and IL-8. Most importantly, dramatically decreased numbers of CD4(+) T cells (approximately eightfold), but not CD8(+) cells, to…

AdultCD4-Positive T-LymphocytesMaleT-LymphocytesT cellLeishmaniasis CutaneousHIV InfectionsDermatologyCXCR3BiochemistryLesionInterferon-gammaYoung AdultCutaneous leishmaniasismedicineHumansLeishmania majorAntigen-presenting cellMolecular BiologyLeishmania majorSkinbiologyCoinfectionFOXP3biology.organism_classificationmedicine.diseasemedicine.anatomical_structureImmunologyFemalemedicine.symptomCD8Experimental Dermatology
researchProduct

Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected pat…

2018

Purpose: We aimed to assess the diagnostic reliability of two indirect biomarkers, APRI and FIB-4, for the staging of liver fibrosis using transient elastography (TE) as reference standard, among HIV/HCV co-infected and HCV mono-infected patients. Methods: This is an observational, retrospective study on subjects who had access to the RESIST HCV from October 2013 to December 2016, a regional network encompassing 22 hospitals and academic centers throughout Sicily. Sensitivity, specificity and diagnostic accuracy of indirect biomarkers for liver stiffness measurement (LSM) < 9.5 kPa (significant fibrosis) and LSM ≥ 12.5 kPa (cirrhosis) were determined by receiver operator characteristics …

AdultLiver CirrhosisMale0301 basic medicineMicrobiology (medical)medicine.medical_specialtyTransient elastographyCirrhosis030106 microbiologyHuman immunodeficiency virus (HIV)HIV InfectionsHepacivirusmedicine.disease_causeGastroenterology03 medical and health sciences0302 clinical medicineLiver Function TestsLiver stiffnessInternal medicineNoninvasive biomarkermedicineHumansAspartate Aminotransferases030212 general & internal medicineSicilyRetrospective StudiesAPRIReceiver operating characteristicCoinfectionbusiness.industryReproducibility of ResultsHIVvirus diseasesRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseHepatitis Cdigestive system diseasesInfectious DiseasesHCVFIB-4Elasticity Imaging TechniquesFemaleUltrasonographyTransient elastographybusinessBiomarkersSignificant fibrosisInfection
researchProduct

Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir.

2015

ABSTRACT Raltegravir pharmacokinetics was studied in 20 patients included in the ANRS HC30 QUADRIH Study before and after addition of anti-hepatitis C virus (anti-HCV) quadritherapy, including pegylated-interferon–ribavirin and asunaprevir plus daclatasvir. Raltegravir pharmacokinetic parameters remained unchanged whether administered on or off anti-HCV therapy. In addition, concentrations of raltegravir, asunaprevir, and daclatasvir were not affected by liver cirrhosis. These data suggest that in human immunodeficiency virus (HIV)-HCV-coinfected patients, whether cirrhotic or not, asunaprevir and daclatasvir could be administered safely with raltegravir.

AdultLiver CirrhosisMaleDaclatasvirPyrrolidinesAlpha interferonHIV InfectionsHepacivirusPharmacologyAntiviral AgentsRaltegravir PotassiumPolyethylene Glycolschemistry.chemical_compoundPharmacokineticsRaltegravir PotassiumRibavirinMedicineHumansPharmacology (medical)PharmacologySulfonamidesbusiness.industryCoinfectionRibavirinImidazolesvirus diseasesInterferon-alphaValineHepatitis CHepatitis C ChronicMiddle AgedRaltegravirmedicine.diseaseIsoquinolinesdigestive system diseasesRecombinant ProteinsInfectious DiseaseschemistryLiverHIV-1AsunaprevirDrug Therapy CombinationFemaleCarbamatesbusinessmedicine.drugAntimicrobial agents and chemotherapy
researchProduct

HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals

2017

Anecdotal reports suggest that patients with chronic hepatitis C virus (HCV) hepatitis and overt or occult hepatitis B virus (HBV) coinfection may reactivate HBV when HCV is suppressed or cleared by direct-acting antivirals (DAAs). We assessed the prevalence of overt or previous HBV coinfection and the risk of HBV reactivation in patients with HCV cirrhosis treated with DAAs. This was a retrospective cohort of 104 consecutive patients with HCV cirrhosis treated with DAAs. Serum HCV-RNA and HBV-DNA were tested at weeks 4, 8 and 12 of DAAs therapy and at week 12 of follow-up. At the start of DAAs, eight patients (7.7%) were HBsAg positive/HBeAg negative with undetectable HBV-DNA and low level…

AdultLiver CirrhosisMaleHepatitis B virusHBsAgCirrhosisHepacivirusHepacivirusmedicine.disease_causeAntiviral AgentsVirus03 medical and health sciencesHepatitis B Chronic0302 clinical medicineVirologymedicineHumansHBV-DNA reactivationnucleos(t)ide analogues therapyAgedRetrospective StudiesHepatitisHepatitis B virusHepatologybiologyCoinfectionbusiness.industryvirus diseasesRetrospective cohort studyHepatitis C ChronicMiddle Agedmedicine.diseasebiology.organism_classificationVirologyprevious HBV infectiondigestive system diseasesInfectious DiseasesHBV/HCV coinfection030220 oncology & carcinogenesisDNA ViralCoinfectionRNA ViralFemaleVirus Activation030211 gastroenterology & hepatologysustained virological responsebusiness
researchProduct

Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa

2017

Treatment for chronic hepatitis B (CHB) is virtually absent in sub-Saharan Africa. Here we present early experiences from a pilot program for treatment of CHB in Ethiopia. Adults (≥18 years) with CHB were included in a cohort study at St. Paul’s Hospital Millennium Medical College, Addis Ababa, from February 2015. The baseline assessment included liver function tests, viral markers and transient elastography (Fibroscan 402, Echosense, France). Logistic regression models were used to identify predictors of fibrosis. Tenofovir disoproxil fumarate (TDF) was initiated based on the European Association for the Study of the Liver (EASL) criteria, with some modifications. The initial 300 patients …

AdultLiver CirrhosisMaleHepatitis B virusmedicine.medical_specialtyCirrhosisPilot ProjectsAntiviral therapyAntiviral Agentslcsh:Infectious and parasitic diseasesCohort StudiesYoung Adult03 medical and health sciencesHepatitis B Chronic0302 clinical medicinePregnancyInterquartile rangeInternal medicinemedicineHumanslcsh:RC109-216Hepatitis B e Antigens030212 general & internal medicinePregnancy Complications InfectiousTenofovirAIDS-Related Opportunistic Infectionsmedicine.diagnostic_testCoinfectionbusiness.industryAlanine TransaminaseMiddle AgedViral LoadHepatitis Bmedicine.diseaseResource-limited settingsInfectious DiseasesHBeAgAfricaImmunologyFemale030211 gastroenterology & hepatologyEthiopiaTransient elastographyLiver function testsbusinessViral loadBiomarkersResearch ArticleCohort study
researchProduct

The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy

2019

Background: There is increasing awareness of HBV reactivation in HCV-RNA-positive/HBV-coinfected patients with chronic liver disease (CLD) treated with oral direct-acting antivirals (DAAs). Aim: To provide figures on the prevalence of HBV markers in HCV-RNA-positive subjects in Italy, where these findings are lacking. Methods: All subjects aged ≥18 years with CLD consecutively referring to Italian liver units located throughout country were prospectively enrolled in two national surveys in 2001 and 2014. Results: The total number of HCV-RNA-positive cases was 6984; 356 (5.1%) subjects vaccinated against HBV were excluded. A total of 6628 cases were evaluated. The prevalence rates of HBsAg, …

AdultLiver CirrhosisMaleHepatitis B virusmedicine.medical_specialtyHBsAgCirrhosisHBV reactivationHbv markersHbv reactivationPrevalenceHbv vaccinationHepacivirusChronic liver diseaseAntiviral Agents03 medical and health sciences0302 clinical medicineInternal medicinePrevalencemedicineHumansHepatitis B AntibodiesReimbursementAgedHepatitis B Surface AntigensHepatologyCoinfectionbusiness.industryGastroenterologyHCV therapyvirus diseasesHepatitis C ChronicMiddle AgedHepatitis Bmedicine.diseaseChronic HCV infection; HBV reactivation; HBV/HCV coinfection; HCV therapydigestive system diseasesHBV/HCV coinfectionItalyChronic HCV infection030220 oncology & carcinogenesisDNA ViralFemaleVirus Activation030211 gastroenterology & hepatologybusiness
researchProduct